Hyeok Shim

1.2k total citations
37 papers, 619 citations indexed

About

Hyeok Shim is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Hyeok Shim has authored 37 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 7 papers in Molecular Biology. Recurrent topics in Hyeok Shim's work include Lymphoma Diagnosis and Treatment (8 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Hyeok Shim is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Hyeok Shim collaborates with scholars based in South Korea, United States and Japan. Hyeok Shim's co-authors include Jae‐Yong Kwak, Na‐Ri Lee, Ho Sung Park, Su‐Bin Lee, Hong‐Seob So, Gi‐Su Oh, Ki‐Eun Hwang, Eun‐Taik Jeong, Keum Ha Choi and Hak-Ryul Kim and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Hyeok Shim

32 papers receiving 617 citations

Peers

Countries citing papers authored by Hyeok Shim

Since Specialization

Citations

This map shows the geographic impact of Hyeok Shim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyeok Shim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyeok Shim more than expected).

Fields of papers citing papers by Hyeok Shim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyeok Shim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyeok Shim. The network helps show where Hyeok Shim may publish in the future.

Co-authorship network of co-authors of Hyeok Shim

This figure shows the co-authorship network connecting the top 25 collaborators of Hyeok Shim. A scholar is included among the top collaborators of Hyeok Shim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyeok Shim. Hyeok Shim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Augmentation of NAD+ by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice	Journal of Inflammation Research	Seung‐Hoon Lee, Hyungjin Kim et al.	4
2	Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study	Supportive Care in Cancer	Woo Kyun Bae, Jihyun Kwon et al.	14
3	A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study	Cancer Research and Treatment	Soyeon Jeon, Hye Sook Han et al.	16
4	Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer	Medicine	So Yeon Lee, Yoon Seok Choi et al.	12
5	Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01	Cancer Research and Treatment	Jung Hye Choi, Tae Min Kim et al.	7
6	Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation	Blood Research	Mark Hong Lee, Inho Kim et al.	3
7	Dunnione ameliorates cisplatin-induced small intestinal damage by modulating NAD+ metabolism	Biochemical and Biophysical Research Communications	Arpana Pandit, Hyung‐Jin Kim et al.	22
8	Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity	Hearing Research	Hyungjin Kim, Gi‐Su Oh et al.	7
9	A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study	The Oncologist	Hye Sook Han, Ji Chan Park et al.	22
10	R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma	Blood Research	Mark Hong Lee, Yunsuk Choi et al.	10
11	Aberrant proteomic expression of NSRP70 and its clinical implications and connection to the transcriptional level in adult acute leukemia	Leukemia Research	Hak-Ryul Kim, Chang‐Duk Jun et al.	3
12	Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions	Clinical & Experimental Metastasis	Do‐Sim Park, Ki‐Eun Hwang et al.	11
13	Matched‐pair analysis comparing the outcomes of primary breast and nodal diffuse large B‐cell lymphoma in patients treated with rituximab plus chemotherapy	International Journal of Cancer	Ho‐Young Yhim, Jin Seok Kim et al.	35
14	Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety	Annals of Hematology	Sung Sook Lee, Cheolwon Suh et al.	16
15	Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin	Investigational New Drugs	Ki‐Eun Hwang, Do‐Sim Park et al.	56
16	The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy	International Journal of Cancer	Ho‐Young Yhim, Na‐Ri Lee et al.	49
17	Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study	BMC Cancer	Ho‐Young Yhim, Hye Jin Kang et al.	54
18	Clinical Features and Treatment Outcomes of Non-Hodgkin's Lymphoma with Breast Involvement; Multi-Institutional Analysis of 98 Patients in Korea.	Blood	Jae‐Yong Kwak, Ho‐Young Yhim et al.	0
19	Recombinant Human Epidermal Growth Factor Accelerates Recovery of Mouse Small Intestinal Mucosa After Radiation Damage	International Journal of Radiation OncologyBiologyPhysics	Joon Pio Hong, Sang-wook Lee et al.	27
20	SIRT1 Expression is Associated With Poor Prognosis of Diffuse Large B-Cell Lymphoma	The American Journal of Surgical Pathology	Kyu Yun Jang, Sung Ho Hwang et al.	105

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact